Published in Anesth Analg on June 01, 1994
A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome. BMC Med Inform Decis Mak (2006) 0.77
Prolonged use of neuromuscular blockers in the intensive care unit. Anesth Analg (1995) 0.75
Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients. Yale J Biol Med (2000) 0.75
New muscle relaxants. West J Med (1995) 0.75
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med (2001) 1.84
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma (1997) 1.64
Cytokine modulation of keratinocyte cytokines. J Invest Dermatol (1990) 1.59
Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. Br J Anaesth (1990) 1.57
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55
Sildenafil modulates hemodynamics and pulmonary gas exchange. Am J Respir Crit Care Med (2001) 1.50
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Effects of epinephrine on intestinal oxygen supply and mucosal tissue oxygen tension in pigs. Crit Care Med (2001) 1.45
Human mast cells produce IL-8. J Immunol (1993) 1.44
Korean hand acupuncture in the treatment of chronic hiccups. Am J Gastroenterol (1998) 1.42
Atrial natriuretic factor release during hypovolemia and after volume replacement. Crit Care Med (1992) 1.39
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol (2003) 1.29
Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med (2000) 1.25
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol (2004) 1.16
The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth (1991) 1.11
Acute respiratory failure associated with catastrophic antiphospholipid syndrome. J Intern Med (2000) 1.10
Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med (2001) 1.06
Reconstruction of large defects on the scalp and forehead as an interdisciplinary challenge: experience in the management of 39 cases. Eur J Surg Oncol (2006) 1.05
Human epidermal cells synthesize HLA-DR alloantigens in vitro upon stimulation with gamma-interferon. J Invest Dermatol (1985) 1.01
4-Aminopyridine kinetics. Clin Pharmacol Ther (1982) 0.97
Management of leukocytoclastic vasculitis. J Dermatolog Treat (2005) 0.97
[Hydroxyethyl starch accumulation in the skin with special reference to hydroxyethyl starch-associated pruritus]. Dtsch Med Wochenschr (2000) 0.96
Some, but not all, glycine substitution mutations in COL7A1 result in intracellular accumulation of collagen VII, loss of anchoring fibrils, and skin blistering. J Biol Chem (1998) 0.96
Effects of 4-aminopyridine in Eaton Lambert Syndrome. Br J Anaesth (1978) 0.95
"Latex-fruit syndrome": frequency of cross-reacting IgE antibodies. Allergy (1997) 0.94
Defective intralesional interferon-gamma activity in patients with lepromatous leprosy. Clin Exp Immunol (1988) 0.94
The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology (1990) 0.94
Suramin reverses non-depolarizing neuromuscular blockade in rat diaphragm. Eur J Pharmacol (1992) 0.94
Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. Eur Urol (2001) 0.94
Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat. J Pharmacol Exp Ther (1978) 0.93
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis (2013) 0.91
Pharmacokinetics of 4-aminopyridine in human volunteers. A preliminary study using a new GLC method for its estimation. Br J Anaesth (1981) 0.91
The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study. Br J Anaesth (1980) 0.91
Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol (2001) 0.89
[Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease?]. Hautarzt (1982) 0.89
Fluorimetric and chromatographic determination of pancuronium bromide and its metabolites in biological materials. Clin Chim Acta (1973) 0.89
Modulatory effects on human sensorimotor cortex by whole-hand afferent electrical stimulation. Neurology (2004) 0.89
Effective treatment of verapamil intoxication with 4-aminopyridine in the cat. J Clin Invest (1984) 0.89
Effects of 4-aminopyridine in elderly patients with Alzheimer's disease. N Engl J Med (1984) 0.87
Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol (1999) 0.86
Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology (2005) 0.86
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy (2006) 0.85
Hair cycle-dependent production of ACTH in mouse skin. Biochim Biophys Acta (1998) 0.85
Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487. Can J Anaesth (1994) 0.85
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
The skin POMC system (SPS). Leads and lessons from the hair follicle. Ann N Y Acad Sci (1999) 0.84
A preliminary investigation of the renal and hepatic excretion of gallamine triethiodide in man. Br J Anaesth (1978) 0.84
Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J Pathol (1993) 0.84
The comparative potency and pharmacokinetics of pancuronium and its metabolites in anesthetized man. J Pharmacol Exp Ther (1978) 0.84
Epidemiology of adverse reactions in anaesthesia in Germany and the Netherlands. Klin Wochenschr (1982) 0.83
Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome? Br J Dermatol (1995) 0.83
[The clinical application of the "locus of resistance" method for axillary plexus block (author's transl)]. Anaesthesist (1981) 0.83
[Weaning an asthmatic using biphasic positive airway pressure together with continuous sufentanil administration]. Anaesthesist (1990) 0.83
Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol (2009) 0.83
Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann N Y Acad Sci (1999) 0.82
The fate of pancuronium bromide in man. Acta Anaesthesiol Scand (1973) 0.82
Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis. Eur J Immunol (1994) 0.82
Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker. J Am Acad Dermatol (1996) 0.82
The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. J Neurol Neurosurg Psychiatry (1981) 0.82
Antagonism of ketamine-diazepam anaesthesia by 4-aminopyridine in human volunteers. Br J Anaesth (1980) 0.82
Age-dependent dose-response relationship of ORG NC 45 in anaesthetized patients. Br J Anaesth (1982) 0.81
Bullous pemphigoid treated with mycophenolate mofetil. Lancet (1997) 0.81
The relationship between disposition and duration of action of congeneric series of steroidal neuromuscular blocking agents. Acta Anaesthesiol Scand (1977) 0.81
The use of rocuronium (ORG 9426) in patients with chronic renal failure. Anaesthesia (1993) 0.81
The fate of pancuronium bromide in the cat. Acta Anaesthesiol Scand (1973) 0.81
Expression of MC1- and MC5-receptors on the human mast cell line HMC-1. Ann N Y Acad Sci (1999) 0.81
The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur J Anaesthesiol Suppl (1995) 0.81
Normolipemic papular xanthomatosis in erythrodermic atopic dermatitis. J Am Acad Dermatol (1995) 0.80
ACTH production in C57BL/6 mouse skin. Ann N Y Acad Sci (1999) 0.80
Direct action of 4-aminopyridine on the contractility of a fast-contracting muscle in the cat. Clin Exp Pharmacol Physiol (1982) 0.80
Comparison of the pharmacological actions of some new 4-aminopyridine derivatives. Eur J Pharmacol (1984) 0.80
Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium and pancuronium in patients with normal and impaired renal function. Anaesthesist (1978) 0.80
Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists. J Eur Acad Dermatol Venereol (2014) 0.80
Cardiovascular and neuromuscular effects of three steroidal neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991). Anesth Analg (1990) 0.80
Reversal by suramin of neuromuscular block produced by pancuronium in the anaesthetized rat. Br J Pharmacol (1993) 0.79
Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth (1978) 0.79
Trans-fascial laparoscopic mesh fixation: a procedural comparison using the standard suture passer versus iMESH stitcher™ device. Hernia (2011) 0.79
Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol (2009) 0.79
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol (2005) 0.79
Pharmacodynamics and reversal of benzodiazepine-ketamine ataranalgesia. S Afr Med J (1981) 0.79
[Hypertriglyceridemia and acute pancreatitis]. Acta Med Austriaca (1994) 0.79
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study. Allergy (2010) 0.79
Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine. Pflugers Arch (1979) 0.78
A child with localized vulval pemphigoid and IgG autoantibodies targeting the C-terminus of collagen XVII/BP180. Br J Dermatol (1999) 0.78
Mucosal tissue oxygenation of the porcine jejunum during normothermic cardiopulmonary bypass. Br J Anaesth (1999) 0.78
Uptake and excretion of vecuronium bromide and pancuronium bromide in the isolated perfused rat liver. Anesthesiology (1988) 0.78
Lethal intoxication by wargases on Iranian soldiers. Therapeutic interventions on survivors of mustard gas and mycotoxin immersion. Arch Belg (1984) 0.78
Haemodynamic effects of vecuronium. Br J Anaesth (1989) 0.78
Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology. J Eur Acad Dermatol Venereol (2013) 0.78
Extended duration of action of rocuronium in postpartum patients. Anesth Analg (1997) 0.78
The pulmonary epithelial cell line L 2 as a new model for an inducible nitric oxide synthase expressing distal airway epithelial cell. Biochem Biophys Res Commun (1995) 0.78
The effect of some new aminopyridines on mammalian non-myelinated nerve fibres. Eur J Pharmacol (1983) 0.78
Exogenous neopterin causes cardiac contractile dysfunction in the isolated perfused rat heart. J Mol Cell Cardiol (2000) 0.78
Porcine model for studying the passage of non-depolarizing neuromuscular blockers through the blood-brain barrier. Br J Anaesth (1992) 0.78